ESMO 23: Opdivo Matches Keytruda In Perioperative Lung Cancer

 
• By Elizabeth Cairns

Bristol Myers Squibb’s PD-1 looks set to follow Merck & Co’s rival in a new lung cancer setting but might second place be the first loser?    

Group of surgeons doing surgery in hospital operating theater. Medical team doing critical operation. -

More from Anticancer

More from Therapy Areas